Development of 3D-QSAR Models to Predict Inhibition Activity of Selective Histone Deacetylase 1-3 Inhibitors
Pharmaceutical Sciences · 31.07.2026 · 32 (3) · 441-450
DOI: 10.34172/ps.42810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 31.07.2026. Verfasst von Narges Cheshmazar und 2 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Introduction
Histone deacetylase inhibitors (HDACIs) have attracted researchers’ attention as anti-cancer agents. Designing novel HDAC inhibitors is important in drug discovery field of HDAC due to their high potency, less off-target effects, and good pharmacokinetic and pharmacodynamic profiles. 3D quantitative structure-activity relationship (3D‐QSAR) is a computational method used to design novel compounds considering 3D structure of molecules.
Methods
In the current study, we have performed two successive QSAR analyses including a classification based for recognizing selective HDAC1-3 inhibitors from non-selective inhibitors and a 3D-QSAR to predict the potency of inhibitors. To this, initially a classification based QSAR was developed to filter selective HDAC1-3 inhibitors from other isoform-selective or pan inhibitors. Also, a receiver operating characteristics (ROC) analysis was performed for evaluation the goodness of classification model performance. Then, three different 3D-QSAR models were developed specifically for the filtered selective HDAC1-3 inhibitors to assess their selectivity and potency.
Results
The generated models revealed that some common structural moieties have positive or negative effect towards the potency of the studied compounds against all three HDAC 1-3 isoforms. The results indicated that out of the identified important variables, a variable named DRY-TIP showing the optimum distance between ZBG and cap group. Furthermore, presence of two HBD groups in ZBD to form pseudoring with a zinc ion present in the active site of the enzyme are essential for exerting inhibitory activity. Using partial least square analysis, a 3D-QSAR model with 5 latent variables was generated with q2 values of internal and external validation equal to 0.62, 0.84, 0.83 and 0.72, 0.90, 0.82 for HDAC1,2,3, respectively.
Conclusion
The result of the current study can be used to recognize selective HDAC1-3 inhibitors and predict their potencies with the aim of selective HDAC1-3 inhibitor design.
Zitieren
APA
Cheshmazar, N., Nasri, A., & Dastmalchi, S. (2026). Development of 3D-QSAR Models to Predict Inhibition Activity of Selective Histone Deacetylase 1-3 Inhibitors. Pharmaceutical Sciences, 32(3), 441-450. https://doi.org/10.34172/ps.42810
Vancouver
Cheshmazar N, Nasri A, Dastmalchi S. Development of 3D-QSAR Models to Predict Inhibition Activity of Selective Histone Deacetylase 1-3 Inhibitors. Pharmaceutical Sciences. 2026;32(3):441-450. doi:10.34172/ps.42810
BibTeX
@article{Cheshmazar2026,
author = {Cheshmazar, Narges and Nasri, Amirhossein and Dastmalchi, Siavoush},
title = {Development of 3D-QSAR Models to Predict Inhibition Activity of Selective Histone Deacetylase 1-3 Inhibitors},
journal = {Pharmaceutical Sciences},
year = {2026},
volume = {32},
number = {3},
pages = {441--450},
doi = {10.34172/ps.42810}
}
EUVIMED